CXCR4 and systemic sclerosis: We also previously showed that SSc-ILD monocytes overexpress the promigratory cytokine receptor CXCR4 on the basis of their underexpression of caveolin-1 and that their overexpression of CXCR4 is reversed by CSD peptide treatment.